Therapeutic and Radiosensitizing Effects of Armillaridin on Human Esophageal Cancer Cells
Open Access
- 1 January 2013
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-8
- https://doi.org/10.1155/2013/459271
Abstract
Background. Armillaridin (AM) is isolated fromArmillaria mellea. We examined the anticancer activity and radiosensitizing effect on human esophageal cancer cells.Methods. Human squamous cell carcinoma (CE81T/VGH and TE-2) and adenocarcinoma (BE-3 and SKGT-4) cell lines were cultured. The MTT assay was used for cell viability. The cell cycle was analyzed using propidium iodide staining. Mitochondrial transmembrane potential was measured by DiOC6(3) staining. The colony formation assay was performed for estimation of the radiation surviving fraction. Human CE81T/VGH xenografts were established for evaluation of therapeutic activityin vivo.Results. AM inhibited the viability of four human esophageal cancer cell lines with an estimated concentration of 50% inhibition (IC50) which was 3.4–6.9 M. AM induced a hypoploid cell population and morphological alterations typical of apoptosis in cells. This apoptosis induction was accompanied by a reduction of mitochondrial transmembrane potential. AM accumulated cell cycle at G2/M phase and enhanced the radiosensitivity in CE81T/VGH cells.In vivo, AM inhibited the growth of CE81T/VGH xenografts without significant impact on body weight and white blood cell counts.Conclusion. Armillaridin could inhibit growth and enhance radiosensitivity of human esophageal cancer cells. There might be potential to integrate AM with radiotherapy for esophageal cancer treatment.
Keywords
Funding Information
- National Science Council (98-2323-B-241-001, MMH-10108)
This publication has 14 references indexed in Scilit:
- DNA Damage Response and Repair: Insights Into Strategies for Radiation Sensitization of GliomasFuture Oncology, 2011
- Antioxidant Properties of the Edible Basidiomycete Armillaria mellea in Submerged CulturesInternational Journal of Molecular Sciences, 2011
- Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology RevisitedThe International Journal of Cell Cloning, 2010
- Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinomaInternational Journal of Medical Sciences, 2009
- Structural elucidation and immunological activity of a polysaccharide from the fruiting body of Armillaria melleaBioresource Technology, 2008
- Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781Journal of Clinical Oncology, 2008
- NF-κB-mediated adaptive resistance to ionizing radiationFree Radical Biology & Medicine, 2007
- Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancerBritish Journal of Cancer, 2007
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992
- Chemical Constituents ofArmillaria melleaMycelium I. Isolation and Characterization of Armillarin and ArmillaridinPlanta Medica, 1984